Healthcare provider profile · identity verified

Christopher James Smith, DO

Family Practice · MONROE, WI · NPI 1538173265

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	485	142
Lisinopril	Lisinopril	340	99
Omeprazole	Omeprazole	280	77
Levothyroxine Sodium	Levothyroxine Sodium	274	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	251	63
Duloxetine Hcl	Duloxetine Hcl	244	68
Morphine Sulfate Er	Morphine Sulfate	209	21
Gabapentin	Gabapentin	205	59
Oxycodone Hcl	Oxycodone Hcl	194	34
Lorazepam	Lorazepam	191	43
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	191	29
Metformin Hcl	Metformin Hcl	148	44
Ozempic	Semaglutide	140	25
Albuterol Sulfate Hfa	Albuterol Sulfate	139	41
Amlodipine Besylate	Amlodipine Besylate	122	43
Losartan Potassium	Losartan Potassium	117	39
Tramadol Hcl	Tramadol Hcl	114	35
Furosemide	Furosemide	112	34
Pregabalin	Pregabalin	112	21
Metformin Hcl Er	Metformin Hcl	103	29
Famotidine	Famotidine	87	30
Hydrochlorothiazide	Hydrochlorothiazide	84	28
Metoprolol Succinate	Metoprolol Succinate	84	24
Allopurinol	Allopurinol	82	26
Pantoprazole Sodium	Pantoprazole Sodium	80	22
Prednisone	Prednisone	80	34
Fluticasone Propionate	Fluticasone Propionate	78	28
Trazodone Hcl	Trazodone Hcl	76	16
Tizanidine Hcl	Tizanidine Hcl	75	20
Potassium Chloride	Potassium Chloride	72	16
Warfarin Sodium	Warfarin Sodium	72	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	21
Tamsulosin Hcl	Tamsulosin Hcl	71	23
Alprazolam	Alprazolam	70	17
Zolpidem Tartrate	Zolpidem Tartrate	64	11
Clonazepam	Clonazepam	60	12
Topiramate	Topiramate	60	12
Bupropion Xl	Bupropion Hcl	59	17
Celecoxib	Celecoxib	57	18
Diazepam	Diazepam	56	suppressed
Spironolactone	Spironolactone	56	19
Jardiance	Empagliflozin	53	13
Meloxicam	Meloxicam	53	18
Simvastatin	Simvastatin	52	16
Ventolin Hfa	Albuterol Sulfate	52	14
Montelukast Sodium	Montelukast Sodium	51	12
Baclofen	Baclofen	50	14
Rosuvastatin Calcium	Rosuvastatin Calcium	48	22
Bupropion Hcl Sr	Bupropion Hcl	47	suppressed
Carvedilol	Carvedilol	47	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	17
Eliquis	Apixaban	46	11
Morphine Sulfate	Morphine Sulfate	45	suppressed
Prazosin Hcl	Prazosin Hcl	45	suppressed
Trulicity	Dulaglutide	43	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	42	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	41	17
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	11
Mounjaro	Tirzepatide	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	39	20
Atenolol	Atenolol	38	suppressed
Bydureon Bcise	Exenatide Microspheres	38	suppressed
Sertraline Hcl	Sertraline Hcl	38	13
Lamotrigine	Lamotrigine	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	14
Pravastatin Sodium	Pravastatin Sodium	34	12
Farxiga	Dapagliflozin Propanediol	33	11
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Fentanyl	Fentanyl	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Nystatin	Nystatin	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Novolog	Insulin Aspart	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Glipizide	Glipizide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Estradiol	Estradiol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Lurasidone Hcl	Lurasidone Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Sulindac	Sulindac	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Finasteride	Finasteride	13	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	13	13
Januvia	Sitagliptin Phosphate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Emgality Pen	Galcanezumab-Gnlm	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error